Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01981863 · ClinicalTrials.gov registry record · Phase 4
Fibrinolysis Before Cardiopulmonary Bypass?
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01981863: Completed Phase 4 study, sponsored by Stanford University.
NCT01981863 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01981863, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
It is common practice to use antifibrinolytic agents before and during cardiopulmonary bypass. They are not without side effects. The investigators want to show that there is no proof of fibrinolysis in standard sternotomy cardiac surgery patients before cardiopulmonary bypass, and that antifibrinolytic agents should only be started on cardiopulmonary bypass.
Interventions
- DRUG Placebo
- DRUG Epsilonaminocaproic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01981863
The ClinicalTrials.gov registry entry for NCT01981863 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01981863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01981863 about?
NCT01981863 is a clinical study titled "Fibrinolysis Before Cardiopulmonary Bypass?". It is common practice to use antifibrinolytic agents before and during cardiopulmonary bypass. They are not without side effects. The investigators want to show that there is no proof of fibrinolysis in standard sternotomy cardiac surgery patients before cardiopulmonary bypass, and that antifibrinol...
What is the current status of trial NCT01981863?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2013-07. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01981863?
The interventions under investigation include: Placebo (DRUG), Epsilonaminocaproic acid (DRUG).
Who is sponsoring clinical trial NCT01981863?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.